Tacrolimus clinical studies for atopic dermatitis and other conditions

Seminars in Cutaneous Medicine and Surgery

Volumn 20, Issue 4, 2001, Pages 250-259

  Bergman, J ^a   Rico, J M ^a  

^a ASTELLAS PHARMA GLOBAL DEVELOPMENT   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PROTROPIC; STEROID; TACROLIMUS; UNCLASSIFIED DRUG;

ARTICLE; ATOPIC DERMATITIS; CLINICAL TRIAL; CONTACT DERMATITIS; DRUG APPROVAL; DRUG EFFICACY; DRUG INDICATION; DRUG INDUCED DISEASE; DRUG SAFETY; FLU LIKE SYNDROME; GRAFT VERSUS HOST REACTION; HAND DISEASE; HUMAN; LICHEN PLANUS; OINTMENT; PEDIATRICS; PYODERMA GANGRENOSUM; ROSACEA; SKIN IRRITATION;

EID: 0035211458     PISSN: 10855629     EISSN: None     Source Type: Journal    
DOI: 10.1053/sder.2001.29061     Document Type: Article

References (68)

1. A short-term trial of tacrolimus ointment for atopic dermatitis
2. A randomized, vehicle-controlled trial of tacrolimus ointment for treatment of atopic dermatitis in children
3. The eczema area and severity index (EASI): Assessment of reliability in atopic dermatitis
4. A 12-week study of tacrolimus ointment for the treatment of atopic dermatitis in pediatric patients
5. Tacrolimus ointment for the treatment of atopic dermatitis in adult patients: Part I, efficacy
6. Tacrolimus ointment for the treatment of atopic dermatitis in adult patients: Part II, safety
7. Long-term safety and efficacy of tacrolimus ointment for the treatment of atopic dermatitis in children
8. Incidence and prevalence of influenza
9. Incidence and prevalence of headache
10. Safety and efficacy of 1 year of tacrolimus ointment monotherapy in adults with atopic dermatitis
11. Longterm treatment with FK506 (tacrolimus) ointment in patients with atopic dermatitis-analysis at the time of 2-year observation
12. Successful treatment of erosive lichen planus with topical tacrolimus
13. Erosive lichen planus: Response to topical treatment with tacrolimus
14. FK506 in the treatment of inflammatory skin disease: Promises and perspectives
15. Anti-inflammatory effect of FK 506 on human skin in mast cells
16. FK506: A new therapeutic agent for severe recalcitrant psoriasis
17. Tacrolimus: Pharmacology and therapeutic uses in dermatology
18. Systemic tacrolimus (FK506) is effective for the treatment of psoriasis in a double-blind, placebo-controlled study
19. IL-8/IL-8 receptor expression in psoriasis and the response to systemic tacrolimus (FK506) therapy
20. Tacrolimus (FK506)-a new therapeutic agent for severe recalcitrant psoriasis
21. Resolution of pyoderma gangrenosum using tacrolimus (FK506)
22. Efficacy of FK 506 in the treatment of recalcitrant pyoderma gangrenosum
23. Resolution of severe pyoderma gangrenosum in a patient with streaking leukocyte factor disease after treatment with tacrolimus (FK506)
24. Update on new immunomodulatory agents
25. Tacrolimus: The drug for the turn of the millennium
26. Preliminary report on the use of oral tacrolimus (FK506) in the treatment of complicated proximal small bowel and fistulizing Crohn's disease
27. Tacrolimus and minidose methotrexate for prevention of acute graft versus host disease after unrelated donor marrow transplantation
28. FK 560 in combination methotrexate for prevention of acute GVHD after related donor marrow transplantation
29. Tacrolimus and methotrexate for the prophylaxis of acute GVHD in allogenic bone marrow transplantation in patients with hematologic malignancies
30. Fk506 rescue in chronic graft-versus-host disease after bone marrow transplantation
31. FK506 (tacrolimus) monotherapy for prevention of graft-versus-host disease after histocompatible sibling allogenic bone marrow transplantation
32. FK506 based immunosuppression for prevention of graft-versus-host disease after unrelated donor bone marrow transplantation
33. Tacrolimus (FK506) alone or in combination with methotrexate or methylprednisolone for prevention of acute graft-versus-host disease after marrow transplantation from HLA-matched siblings: A single center study
34. Combination therapy with tacrolimus and anti-thymocyte globulin for the treatment of steroid-resistant acute-graft-versus-host disease developing during cyclosporine prophylaxis
35. Differential effects of FK 506 and cyclosporin on hair regrowth in the DEBR model of alopecia areata
36. Experimental treatment of autoimmune MRL-lpr/lpr mice with immunosuppressive compound FK 506
37. Effect of FK 506, a novel immunosuppressive on murine systemic lupus erythematosus
38. FK506: Therapeutic effects on lupus dermatoses in autoimmune prone MRL/MP-lpr/lpr mice
39. Treatment of severe and difficult cases of systemic lupus erythematosus with tacrolimus. A report of 3 cases
40. Pulmonary infiltrates recovered by FK506 in a patient with Behcet's disease
41. Cyclosporin and tacrolimus: Their use in a routine clinical setting for scleroderma
42. The side effects of FK506 in humans
43. Topical tacrolimus may be effective in the treatment of oral and perineal Crohn's disease
44. Sweets syndrome and erythema nodosum in ulcerative colitis, refractory to steroid: Successful treatment with tacrolimus
45. Inhibition of contact allergy reactions by topical FK506
46. Topical tacrolimus (FK506): Percutaneous absorption and effect on allergic and irritant contact dermatitis
47. Topical FK506: Suppression of allergic and irritant contact dermatitis in the guinea pig
48. Tacrolimus ointment for the treatment of steroid-induced rosacea: A preliminary report
49. Clinical picture. Eosinophilic pustular folliculitis
50. Topical tacrolimus for pyoderma gangrenosum
51. Topical tacrolimus for pyoderma gangrenosa
52. Parastomal pyoderma gangrenosum: Clinical features and management
53. Tacrolimus ointment improves psoriasis in a microplaque assay
54. Topical tacrolimus is effective for facial lesions of psoriasis
55. Topical tacrolimus is not effective in chronic plaque psoriasis
56. Topical FK506: A potent immunotherapy for alopecia areata? Studies using the experimental bald rat model
57. Stimulation of hair growth by topical application of FK 506, a potent immunosuppressive agent
58. Rapid hair growth in refractory alopecia universialis associated with autoimmune disease following liver transplant and tacrolimus therapy
59. Topical immunosuppression in skin grafting with FK 506 ointment
60. Prolonged survival of rat skin allograft by treatment with FK 506 ointment
61. The use of FK 506 and skin allografting for the treatment of severe burns in an animal model
62. Use of tacrolimus ointment (TO) in 3-6 years olds with atopic dermatitis (AD): Dose-escalation study
63. Tacrolimus ointment (TO) for adults with moderate to severe atopic dermatitis (AD): A dose escalation study
64. Early phase II study of FK 506 ointment on atopic dermatitis
65. Tacrolimus ointment for atopic dermatitis